Literature DB >> 11017193

Functional defects of pathogenic human mitochondrial tRNAs related to structural fragility.

S O Kelley1, S V Steinberg, P Schimmel.   

Abstract

Aminoacylation of transfer RNAs (tRNAs) is essential for protein synthesis. A growing number of human diseases correlate with point mutations in tRNA genes within the mitochondrial genome. These tRNAs have unique sequences that suggest they have fragile structures. However, the structural significance of pathology-related tRNA mutations and their effects on molecular function have not been explored. Here, opthalmoplegia related mutants of a human mitochondrial tRNA have been investigated. Each mutation replaces either an A-U or G-C pair in the predicted secondary structure with an A-C pair. Aminoacylation of each mutant tRNA was severely attenuated. Moreover, each strongly inhibited aminoacylation of the wild type substrate, suggesting that the effects of these mutations might not be bypassed in the potentially heteroplasmic environment of mitochondria. The function of mutant tRNAs was rescued by single compensatory mutations that restored Watson-Crick base pairing and reintroduced stability into regions of predicted secondary structure, even though the pairs introduced were different from those found in the wild type tRNA. Thus, functional defects caused by a subset of pathogenic mutations may result from the inherent structural fragility of human mitochondrial tRNAs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11017193     DOI: 10.1038/79612

Source DB:  PubMed          Journal:  Nat Struct Biol        ISSN: 1072-8368


  23 in total

Review 1.  Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?

Authors:  C Florentz; M Sissler
Journal:  EMBO Rep       Date:  2001-06       Impact factor: 8.807

2.  Pathology-related substitutions in human mitochondrial tRNA(Ile) reduce precursor 3' end processing efficiency in vitro.

Authors:  Louis Levinger; Richard Giegé; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2003-04-01       Impact factor: 16.971

Review 3.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

4.  Analysis of the fitness effect of compensatory mutations.

Authors:  Liqing Zhang; Layne T Watson
Journal:  HFSP J       Date:  2008-12-03

Review 5.  The emerging complexity of the tRNA world: mammalian tRNAs beyond protein synthesis.

Authors:  Paul Schimmel
Journal:  Nat Rev Mol Cell Biol       Date:  2017-09-06       Impact factor: 94.444

6.  Compensatory evolution in mitochondrial tRNAs navigates valleys of low fitness.

Authors:  Margarita V Meer; Alexey S Kondrashov; Yael Artzy-Randrup; Fyodor A Kondrashov
Journal:  Nature       Date:  2010-02-24       Impact factor: 49.962

Review 7.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases.

Authors:  Ligia Elena González-Serrano; Joseph W Chihade; Marie Sissler
Journal:  J Biol Chem       Date:  2019-01-15       Impact factor: 5.157

8.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

9.  Aminoacylation properties of pathology-related human mitochondrial tRNA(Lys) variants.

Authors:  Marie Sissler; Mark Helm; Magali Frugier; Richard Giege; Catherine Florentz
Journal:  RNA       Date:  2004-05       Impact factor: 4.942

10.  Mutational analysis of the mitochondrial tRNA genes and flanking regions in umbilical cord tissue from uninfected infants receiving AZT-based therapies for prophylaxis of HIV-1.

Authors:  Salina M Torres; Dale M Walker; Consuelo L McCash; Meghan M Carter; Jessica Ming; Edmund M Cordova; Rachel M Pons; Dennis L Cook; Steven K Seilkop; William C Copeland; Vernon E Walker
Journal:  Environ Mol Mutagen       Date:  2009-01       Impact factor: 3.216

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.